A. M. Abd El-Aty, Cairo University, Egypt
Featured article and editorial: incorporating lettuce or watercress into your diet
We are proud to publish a new article by Javad Nasrollahzadeh and co-authors, and an associated editorial by Gregory C. Henderson. Postprandial responses to food mostly depend on the composition of the meal and the consumption of vegetables may modulate this postprandial state. In this study, the effects of lettuce or watercress consumption with a moderately high-fat meal (40% kcal from fat) on postprandial lipemia, glycemia, and inflammatory cytokines were determined in healthy men.
Featured series: Lipids and Sleep
Lipids in Health and Disease is calling for submissions to our new Collection on "Lipids and Sleep". This Collection is focusing on the link between sleep and lipid metabolism. We invite original research, topical and systematic review articles and meta-analyses. For more information on the scope please click here.
Featured series: Nanomaterials/Biomaterials Target Lipid Metabolism and Fight Diseases
Lipids in Health and Disease is calling for submissions to our new Collection on "Nanomaterials/Biomaterials Target Lipid Metabolism and Fight Diseases". With this Collection we hope to provide a platform for communication and discussion of the pharmacological mechanism of nanobiotechnology and lipid metabolism. Read more about the scope here.
Featured series: Lipid Metabolism in Nonalcoholic Fatty Liver Disease
We are calling for submissions to our new Collection which will highlight several topics including: early detection of nonalcoholic fatty liver disease (NAFLD), current therapy for NAFLD, new targets for treating NAFLD, treatment to reduce cardiovascular risks associated with NAFLD, and translational implications and challenges of lipid metabolism in NAFLD. Read more about the scope here.
Featured series: Lipid Abnormalities in ASD and ASD-Associated Genetic Disorders and the Associated mTOR Pathway
We are calling for submissions to our new Collection which will highlight lipid abnormalities identified in autism spectrum disorder (ASD) and ASD-associated genetic disorders, including Smith Lemli Opitz syndrome, Rett syndrome, fragile X syndrome, tuberous sclerosis, neurofibromatosis types 1 and 2, Angelman syndrome, Down syndrome and PTEN hamartoma tumor syndrome and the relationship of ASD-associated genetic disorders to the mTOR pathway. Read more here.
Featured series: Lipids in Inflammatory Diseases
We are proud to announce a new thematic series, guest edited by Christine Meisinger and Jakob Linseisen. The aim of this series is to collect research papers to generate new insights into the role of lipids in the context of acute and chronic inflammatory diseases. We welcome articles, including original research, systematic reviews and meta-analyses on this relevant topic. You can read more about the scope here.
Featured series: Metabolic regulation of lipids and fatty acids and risk of cardiometabolic disease
We are proud to announce a new thematic series, guest edited by Vibeke Telle-Hansen. This collection of papers addresses the role of lipids and lipid metabolism in cancer. We warmly welcome all articles and reviews on solid and non-solid tumors. We aim to include original research and up-to-date reviews on individual regulation of lipids and fatty acids, in relation to different risk profiles (metabotypes) of cardiometabolic disease. You can read more about the scope, here.
Featured series: Sphingomyelin- Key Roles in Health and Disease
We are proud to announce a new thematic series, guest edited by Rashika El Ridi and Junfei Jin. We wish to welcome articles, including original research, narrative reviews, systematic reviews and meta-analysis, and mini-reviews which establish the relation between sphingomyelin metabolism and cancer immune evasion, thus allowing the discovery of unprecedented approaches and new molecules for cancer prevention and therapy. Find out more about the scope here.
Featured series: Role of lipids and lipid metabolism in cancer
We are proud to announce a new thematic series, guest edited by Christa Buechler and Luiz Fernandes. This collection of papers in this addresses the role of lipids and lipid metabolism in cancer. There is emerging evidence that lipids and lipid metabolism are essential for cancer growth. The identification of suitable serum lipid biomarkers as diagnostic tools is in the focus of current research. Lipid metabolism may also become a target for cancer therapy. We warmly welcome all articles and reviews on solid and non-solid tumors.. Find out more about the scope here.
Featured series: Targeting Lipids for Cardiovascular Health: Novel Mechanisms and Therapeutics
We are proud to announce a new thematic series, guest edited by Felice Gragnano, Arturo Cesaro and Paolo Calabrò. People who maintain ideal cardiovascular health have a high life expectancy and a low lifetime risk of disabling and life-threatening medical conditions. Therefore, the identification and adoption of novel strategies to pursue ideal cardiovascular health represent a vital opportunity to improve the prevention and treatment of cardiovascular diseases. Find out more about the scope here.
Please check out the LHAD articles with the highest Altmetric scores, since our journal launched in 2002. Altmetric calculates a score based on the online attention an article receives. Social media and mainstream news media are the main sources that calculate the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Have a submission you want to make sure is right for Lipids in Health and Disease? Or a great idea for a new submission or thematic series? Tell our Editor-in-Chief, A. M. Abd El-Aty!
Aims and scope
Lipids in Health and Disease is an open access, peer-reviewed journal that publishes articles on all aspects of lipids: their interaction with proteins, (bio) chemistry, (molecular) pharmacology, (molecular) toxicology, natural products chemistry, role in health and disease, in addition to the synthesis of new lipid compounds, and enzyme systems involved in lipid metabolism.
Lipids in Health and Disease is aimed at all scientists, health professionals, and physicians interested in lipids. Lipids are defined herein based on their broadest sense, to include: cholesterol, essential fatty acids, saturated fatty acids, phospholipids, inositol lipids, second messenger lipids, enzymes, and synthetic machinery that is involved in the metabolism of various lipids in the cells and tissues, and also various aspects of lipid transport. In addition, the journal also publishes research that investigates and defines the role of lipids in various physiological processes, pathology, and disease. In particular, the journal aims to bridge the gap between the bench and the clinic by publishing articles that are particularly relevant to human diseases and the role of lipids in the management of various diseases.
Reviewers of the quarter
Lipids in Health and Disease is pleased to implement a new platform of recognition every quarter, for the peer reviewers who provided the best performance along the parameters of acceptance rate, scrutiny of the reviews, completion, accepted-completion %, On time delivery-Completion %, and our Editor-in-Chief's evaluation rate. Please click here, to learn about our Reviewers of the Quarter.
Annual Journal Metrics
2022 Citation Impact
4.5 - 2-year Impact Factor
4.9 - 5-year Impact Factor
1.358 - SNIP (Source Normalized Impact per Paper)
1.042 - SJR (SCImago Journal Rank)
3 days submission to first editorial decision for all manuscripts (Median)
82 days submission to accept (Median)
6,558 Altmetric mentions